Legend Biotech Corp (LEGN) earnings: date, estimates and history
Price $16.53 · data as of November 16, 2026
Next earnings report
The date appears here once Legend Biotech confirms it, usually two to four weeks before the report.
Track record
Legend Biotech beat the consensus earnings estimate in 2 of its last 5 reports, by +372.2% on average. On report days the stock moved 8.2% on average, up or down.
Earnings history
| Reported | EPS estimate | EPS actual | Surprise | Revenue | Revenue growth | Stock move |
|---|---|---|---|---|---|---|
| November 10, 2026 Sep/2026 | $0.01 | $0.28 | +2700.0% | — | — | −19.6% |
| August 11, 2026 Jun/2026 | $0.28 | $0.32 | +14.3% | — | — | −0.1% |
| May 12, 2026 Mar/2026 | $-0.02 | $-0.15 | −650.0% | — | — | +12.1% |
| March 10, 2026 Dec/2025 | $0.19 | $-0.16 | −184.4% | — | — | +5.9% |
| November 12, 2025 Sep/2025 | $-0.18 | $-0.22 | −18.9% | — | — | −3.2% |
EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.
Frequently asked questions
When is Legend Biotech’s next earnings date?
Legend Biotech has not confirmed its next report date yet. Its last report was on November 10, 2026.
Did Legend Biotech beat earnings last quarter?
Yes, it reported EPS of $0.28 on November 10, 2026 against an estimate of $0.01 (a +2700.0% surprise), and the stock moved −19.6% the next trading day.
What EPS do analysts expect next quarter?
The consensus estimate is $0.07 per share on revenue of about $360M.
Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar